Semaglutide may cause side effects such as nausea, vomiting, diarrhea, abdominal pain, constipation, allergic reactions, acute kidney injury, pancreatitis, gallbladder problems, diabetic retinopathy, and abnormal behaviors.
Curve timing may shift due to slowed transit
The mechanism is dual-action
See all FAQs Important safety information and common side effects Wegovy Pill should be used with a reduced-calorie meal plan and increased physical activity
At OClinic , we ensure: Correct prescribing by experienced doctors Fat loss, not muscle loss , through expert dietary and protein support Cost-effective access to medication including microdosing techniques Proper dietary nutritional, medical, psychological & lifestyle coaching during our specially curated 6-month program to ensure that you are properly monitored and supported Regular blood tests to ensure healthy nutritional parameters and document improved health Whats Included All for Just $990 (Medication purchased separately from pharmacy) Program Inclusions Details Initial Consultation Medical assessment & medication prescription 6 x Monthly Reviews Adjustments, support & monitoring (in-person or Telehealth) 3 x Blood Tests Baseline + progress tracking 3 x Dietitian Consults Tailored nutrition to protect muscle/bone mass Monthly Webinars Mindset, behavioural coaching & emotional eating support Final Review with Dr Craig Taylor Long-term planning with leading weight loss specialist Medications We Use We prescribe the full range of medically approved weight loss medications : Mounjaro (Tirzepatide) Activates both GLP-1 and GIP receptors Helps reduce appetite and improves insulin sensitivity Results in up to 15-20% weight loss Wegovy (Semaglutide) / Ozempic (heavily subsidised if you have diabetes) GLP-1 receptor agonist Controls appetite, slows digestion, promotes fullness 10-15% average weight loss Other Available Options: Topamax, Contrave, Duromine, Xenical, Saxenda, prescribed based on your unique needs
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice
